+65.3%
GSK vs WST
+24.3%
+41.0%
-28.5%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 3y.
| Period | Portfolio | WST | Excess | Alpha |
|---|---|---|---|---|
| 1D | +0.5% | +1.2% | -0.7% | +0.4% |
| 7D | +1.1% | +4.2% | -3.1% | +0.8% |
| 30D | +6.3% | +11.2% | -4.9% | +5.3% |
| 3M | +1.8% | +20.4% | -18.6% | +0.1% |
| 6M | +1.7% | +37.9% | -36.2% | -1.4% |
| YTD | +6.5% | +51.8% | -45.2% | +2.1% |
| 1Y | +9.5% | +56.6% | -47.1% | +4.6% |
| 3Y | +65.3% | +24.2% | +41.1% | +58.4% |
| All | +65.3% | +24.3% | +41.0% | +58.4% |
Cumulative growth
Daily Returns
Daily percentage return beside WST.
Daily Out/Under-Performance
Portfolio return minus WST return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × WST return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 3y: compounded portfolio wealth divided by compounded WST wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
3y analysis · Full analysis span regression · 6 months rolling